Correlation Between Western Digital and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Western Digital and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Western Digital and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Western Digital and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Western Digital and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Western Digital with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Western Digital and Conduit Pharmaceuticals.
Diversification Opportunities for Western Digital and Conduit Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Western and Conduit is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Western Digital and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Western Digital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Western Digital are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Western Digital i.e., Western Digital and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Western Digital and Conduit Pharmaceuticals
Considering the 90-day investment horizon Western Digital is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Western Digital is 10.71 times less risky than Conduit Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1.10 in Conduit Pharmaceuticals on October 5, 2024 and sell it today you would lose (0.44) from holding Conduit Pharmaceuticals or give up 40.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 67.74% |
Values | Daily Returns |
Western Digital vs. Conduit Pharmaceuticals
Performance |
Timeline |
Western Digital |
Conduit Pharmaceuticals |
Western Digital and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Western Digital and Conduit Pharmaceuticals
The main advantage of trading using opposite Western Digital and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Western Digital position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.Western Digital vs. NetApp Inc | Western Digital vs. Logitech International SA | Western Digital vs. HP Inc | Western Digital vs. Dell Technologies |
Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |